{"id":272453,"date":"2025-07-18T16:15:29","date_gmt":"2025-07-18T16:15:29","guid":{"rendered":"https:\/\/www.europesays.com\/uk\/272453\/"},"modified":"2025-07-18T16:15:29","modified_gmt":"2025-07-18T16:15:29","slug":"ozempic-set-to-become-more-affordable-accessible-in-canada-raising-concerns-of-drug-abuse-ctv-news","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/uk\/272453\/","title":{"rendered":"Ozempic set to become more affordable, accessible in Canada \u2014 raising concerns of drug abuse – CTV News"},"content":{"rendered":"
    \n
  1. Ozempic set to become more affordable, accessible in Canada \u2014 raising concerns of drug abuse<\/a>  CTV News<\/li>\n
  2. Hims & Hers Announces Planned 2026 Expansion to Canada, Following ZAVA Acquisition Completion<\/a>  Hims<\/li>\n
  3. 13 Best Booming Stocks to Buy Now<\/a>  Insider Monkey<\/li>\n
  4. Hims & Hers to offer generic semaglutide in Canada as Novo Nordisk patent lapses<\/a>  CNBC<\/li>\n
  5. Cheaper generic Ozempic is coming to Canada after Novo Nordisk fails to pay patent fee<\/a>  National Post<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"Ozempic set to become more affordable, accessible in Canada \u2014 raising concerns of drug abuse  CTV News Hims &…\n","protected":false},"author":2,"featured_media":264211,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4315],"tags":[834,105,4326,16,15],"class_list":{"0":"post-272453","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-medication","8":"tag-apple-news","9":"tag-health","10":"tag-medication","11":"tag-uk","12":"tag-united-kingdom"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@uk\/114875133024880078","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/272453","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/comments?post=272453"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/272453\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media\/264211"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media?parent=272453"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/categories?post=272453"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/tags?post=272453"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}